Blogs
My Experience as a COVID19 Vaccine Trial Participant
I have been an investigator for many clinical rheumatology studies over the past two decades but have never been a study subject until now. On October 31, 2020, I enrolled in the phase 3 trial of the Pfizer/BioNTech mRNA vaccine against SARS-CoV2 (protocol C4591001). Here's my experience.Telemedicine: What's Changed and What Needs to be Addressed?
Along with our patients, we've spent the last several months adapting to telemedicine. Following is an update on legislative changes and uncertainties, a look at the care gap that may still exist, and examining the trajectory of telemedicine after the initial rapid growth spurred by COVID-19.Rheuma-Yogi-ology
Kathryn Dao, MD and Deedre Morales